Member Info for borrowfundsfrommummy

Https://x.com/labgrownleather/status/2064642197119492203

Along with public viewing now open twitter post from bsfa

1.3p paid .. won’t take much to set this one off

Right taken some for auction tomorrow… I feel some volume may appear later today going into tomorrow..

See how many narcissistic people bid on it .. brand beckham types for sure

So customer base here is 400000 . Tap earn taken $3.5 million in deposits .. 65% shares held by major holders including boss .. this will move at some point … watching for results end of month but feel might be more news on tap earn before then

Well nice trade early on the mfai from yesterday.. have finally put some in bsfa for tomorrow’s auction

Rcgh placing which no surprise on rise .. there customer base very small though 2500 customers or something ..

Few more into tap global today … feels close to bottom zone and results due end of month … there customer base is 400000 and earn app took $3.5 million on first week

Taken a punt on the Mfai .. seems volume follows from one to the other at the moment..

AKN appeared on my tracker but reading that’s alba minerals new name

Taken a few .. feel it might move on volume for sure .. see where the next trend followers end up

Nope .. 😂😂😂 I was just reading up the nhs site on the tablets hence what i posted originally.. I will keep quiet on the subject now

The price for the weight loss program though is interesting

Wonder if that will be paid for by NHS or part funded ??

I stand corrected as it’s on an RNS from the company

The Board anticipates that Novo Nordisk's once-daily oral semaglutide 25 mg weight-management pill, approved by the FDA in December 2025 and submitted to the EMA and other regulatory authorities during the second half of 2025, could receive UK approval during summer 2026. The Board believes that a pill-based GLP-1 option could bring a new cohort of customers into the market, including patients who may be reluctant to start injection-based treatment. There can be no certainty as to UK regulatory approval, timing, supply, clinical availability or prescribing requirements.

The cost to sign up for the ⁠MedPal AI weight loss programme generally operates on a monthly or annual subscription, starting at £3.99 per month (or £29.99 per year) for the core wellness app ⁠MedPal AI.However, enrolling in their medically supervised weight loss service involves several additional factors:Consultation Fees: You will need to pay for an initial medical or clinical consultation MedPal AI to assess your eligibility for GLP-1 medications (such as Wegovy or Mounjaro).Medication Costs: Prescription treatments are charged privately, with standard GLP-1 medications typically ranging from £89 to over £300 per month depending on the medication and dosage ⁠Well Pharmacy, ⁠Bolt Pharmacy.

Wegovy pills not yet approved by the MHRA and we’re looking at end of year for approval for those .. even though they have FDA approval in the states ..

I think signing up to med pal is about £200 a month for it’s current weight loss program

Could be a very interesting XMAS here as the pill will no doubt appeal to more people than the jab

I don’t know where this summer wegovy approval is being touted from as it’s not that soon in the UK

Mpal nice rise above the 3p . I think end of year for the weight loss drug to be approved in the UK so no doubt some up and downs there

This bit of the RNS is also decent

Thor is fully self-funded to undertake this significant data acquisition, providing meaningful asset maturation without dilution to shareholder interests. These data will serve as the keystone for unifying our insights and illuminating the full geological configuration of the highest-grade focus areas.

Yes i know .. tap has already launched though .. that’s my point ..

Tap to follow next on the fintech risers perhaps ..

Think tap will follow the rise on Rcgh next

Nice RNS on the thr hydrogen found .. maybe they are going to turn around into a helium/hydrogen company after all

Things may just be turning a corner here …

I think the round 100000 and 150000 sells possibly from placings as seem to hit at the 2.7p mark

Valkor is currently drilling exploration and pilot wells at its Asphalt Ridge project in Utah, with a planned autumn 2026 drilling window for new joint-venture wells on adjacent leases. The company is executing a phased pilot program targeting heavy sweet oil and oil sands extraction.Key project timelines and drilling milestones include:Asphalt Ridge Pilot Wells: Valkor has previously secured state drilling permits, advanced their field surveys, and raised over US$15 million in project financing to drill and develop the Primary Project Site.Deep Well Trials: The company is testing specialized drilling techniques to reach deeper oil below the main oil-sands layer, aiming to optimize a commercially viable methodology.Joint Leases in Uintah County: Through their joint operating agreement with TomCo Energy, Valkor is targeting autumn 2026 to commence operations on the neighbouring Lease Area.Production Goals: Alongside ongoing drilling and well stimulation, Valkor aims to construct and commission a fully funded, full-scale asphalt extraction plant, targeting production by the end of 2026.You can find official company updates and corporate developments via the ⁠Valkor Group News hub.